Speakers 

 Mohamed Abdel-Mottaleb

Mohamed Abdel-Mottaleb (Nile University, Egypt)

Nanotechnology: Opportunities and Challenges for the Middle East

Mohamed Abdel-Mottaleb, Ph.D. is one of the leading figures facilitating the introduction of nanotech to the Middle East. He is Assistant Professor of Nano Materials and founder and Director of the Nano Materials Masters Program (the first such program in the Middle East).

Prior to joining Nile University, he is the Chairman and Founder of SabryCorp Ltd. (Cairo, Egypt), the first company in the Middle East and Africa to specialize in nanotechnology. Prior to founding SabryCorp, Dr. Abdel-Mottaleb worked in research labs both Belgium (K. U. Leuven) and in Germany (U. Ulm, TU Chemnitz) where he specialized in using Scanning Tunneling Microscopy (STM) and Atomic Force Microscopy applications in surface modifications and device fabrication. Both represent powerful techniques for viewing and manipulating surfaces at the atomic-level. In addition to his work on STM, Dr. Abdel-Mottaleb also worked on constructing molecular nano-wires as well as investigated the blinking phenomenon of quantum dots.

Dr. Abdel-Mottaleb's research has been at the forefront of nanotechnology developments. He has 24 peer-reviewed publications (including papers in Accounts of Chemical Research and Nano Letters) and has recently co-authored a chapter for NATO on the commercial applications of nanotechnology. Further, he has organized and chaired the first nanotech conference in the Middle East (NanoTech Insight, in 2005, 2007), and is currently organizing a host of other industry-specific nanotech events and workshops in the region. In addition, Dr. Abdel-Mottaleb has a strong background in nano materials, as well as alternative energy and sensor technologies.

 Mostafa Analoui

Mostafa Analoui (The Livingston Group - New York, NY)

Nanobiotechnology- From Concept to Market: Global Science and Business Perspectives

Mostafa Analoui, Ph.D., is Head of Healthcare and Life Science at The Livingston Group (New York, NY) and Senior Vice President of Business Development at Charlesson Pharmaceuticals. Previously he was the Senior Director at Pfizer Global Research and Development in Connecticut. He is also adjunct Professor of Radiology and Oral Pathology, Medicine at Indiana University Schools of Medicine and Dentistry. Dr. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies.

Prior to joining Pfizer, Dr. Analoui was the Director of Oral and Maxillofacial Imaging Research at Indiana University, and Associate professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc. In addition to industry leadership in biomedical and technology fields, he lectures and consults nationally and internationally. He has also served on various scientific, regulatory, and business advisory committees and boards. Dr. Analoui has authored over 130 publications, including journal articles, book chapters, and technical reports.

URL:http://www.axiomcapital.com/

 Peter Hatto

Peter Hatto (IonBond Limited, UK)

International standards for nanotechnologies - supporting innovation, safety and responsibility

Dr Peter Hatto has been chairman of the International Organization for Standardization Technical Committee for Nanotechnologies, ISO/TC 229, since it was established in June 2005, and has recently been appointed chairman of the equivalent European (CEN) Technical Committee, TC 352. He is also chairman of the UK BSI committee in the area, NTI/1, a position which he has held since its inception over four years ago.

Peter’s is Director of Research for IonBond Ltd, a leading producer of advanced, thin film, ceramic coatings. His research activities have covered subjects ranging from erosion protection for aircraft engines to enhanced osseo-integration of dental and orthopaedic implants, including two major nanotechnology projects – one on the preparation and characterization of nanostructured multilayer coatings and the other, currently ongoing, on the development and use of nanocomposite coatings for the control of friction and wear in engineering components. His long association with this area of technology led to his appointment in the late 90’s as convenor of working groups for standardization in the field of ceramic coatings in both ISO and CEN, position which he still holds.

 Marek Michalewicz

Marek Michalewicz (Quantum Precision Instruments, Singapore)

Brave new world of (nano)-sensing: The next technological revolution and Quantum-Pi’s sensors.

Dr Marek T. Michalewicz, Quantum-π Founder, Director and Chief Scientific Adviser Skills: Strategic, technical, operational and day-to-day business management, experience in start-up high-tech companies, fund raising, investors relations, business planning, accounting and financial planning, software skills.

Business Studies: "Business Planning for Innovative Technologies" - graduate course at the School of Finance and Management, The University of Minnesota, USA; Project Management courses (CSIRO, Australia).
He received a PhD degree in physics from The Australian National University in Canberra in 1987. Until June 2000 Marek was a Principal Research Scientist at the Commonwealth Scientific and Industrial Research Organisation (CSIRO Australia). He is the inventor of the Quantum-π technology platform patent for tunnelling devices and sole inventor or coinventor of four other Quantum-π patents.

Research expertise and interests: Nanotechnology, Theoretical and Computational Condensed Matter Physics, Surface Science, Computational Quantum Chemistry, Physical Chemistry, Supercomputing and Parallel Computing and Computational Life Sciences. Organised three scientific meetings (two international). Edited two books on Computational Life Sciences. Author of over 30 scientific refereed papers and book chapters and 58 conference presentations in 12 countries .

 Reyad I. Sawafta

Reyad I. Sawafta (QuarTek Corporation, USA)

Nanotechnology Enabled Textiles

Dr. Reyad Sawafta is the president and chief executive officer of QuarTek Corporation, a privately-held nanotechnology company that he founded in 2004. He is also the president and chief executive officer of the NC Nanotechnology accelerator a business and technology development center for start-up companies that own nanotech innovations with significant commercial potential that he also founded in 2006. In his roles, he oversees a myriad of business functions, keeps abreast on new developments in science and technology, devotes attention to the complexities associated with research and development, and continues to apply his innate drive and ambition to foster bright and prosperous futures for these organizations.

Prior to founding QuarTek Corporation, he held various positions of increasing responsibility in academic and research institutions such as Indiana University, Houston, the University of North Carolina System and the US Department of Energy. He has also held various positions in private industry including Vice President of Technology at TransTech Pharma and President & CEO of PharmaCore. Dr. Sawafta has served on numerous national and international advisory committees and boards, and has received many prestigious awards. His expertise includes nanotechnology, biotechnology, nuclear physics, high speed technology, magnetic applications and designs. Dr. Sawafta obtained his Ph.D. in Nuclear Physics from the University of Alberta, Canada in 1986. Dr. Sawafta has authored more than 150 scientific papers and has presented more than 100 invited talks worldwide. Dr. Sawafta is also an inventor on numerous patents and patent applications some of which have been reduced to practice in robotics and automation, computational modeling, data capture and visualization, alternative energy, antimicrobial technologies, environmental friendly polymers and innovative water purification and disinfection technologies.

 Peter Stewart

Peter Stewart (Managing Partner, Dubai Office Curtis, Mallet-Prevost, Colt & Mosle LLP, UAE)

Fund Raising in an Evolving Regulatory and Economic Environment.

Mr. Stewart is a corporate lawyer and the managing partner of the Dubai office of Curtis, Mallet-Prevost, Colt & Mosle LLP, an international law firm of 250 lawyers. He is a member of the firm's Private Equity, Venture Capital, Mergers and Acquisitions, and Capital Markets groups. His private equity practice includes assisting private equity and venture capital funds making investments worldwide. Mr. Stewart also has significant experience representing operating companies working with emerging technologies, including biotechnology/life sciences and nanotechnology. He has been a frequent speaker at conferences addressing nanotechnology particularly. Mr. Stewart studied law at Boston University and engineering at the Massachusetts Institute of Technology. He worked for several years in Silicon Valley, California prior to relocating to New York and then to the Middle East.

 Scott E. Rickert

Scott E. Rickert (Nanofilm, USA)

Nano-izing today's surfaces to solve energy, environmental, and waste problems.

Nanofilm Co-Founder, President and Chief Executive Officer.
Dr. Rickert is among the earliest pioneers to recognize the immense, untapped potential of nanotechnology. In 1985, Dr. Rickert founded Nanofilm, built on the foundation of his innovative research at Case Western Reserve University and commercialized its first patented nano-scale film that same year. Today, Nanofilm is bringing nanotechnology-based products to the energy, transportation, precision optics, displays, architecture, and home products markets around the globe. The staff of 50 works in a 65,000-square-foot research, lab, and production space in Cleveland, Ohio, U.S.A.

Dr. Rickert’s scientific knowledge and deep experience in nanotechnology commercialization has made him a trusted voice for a variety of industries, government entities, global organizations and policy development groups, including the World Economic Forum, the Environmental Protection Agency, the NanoBusiness Alliance, and the U.S. government. He writes a monthly nanotechnology column for IndustryWeek magazine.

 Harald F. Krug

Harald F. Krug (Empa - Materials Science & Technology, Switzerland)

Small stuff, big concerns (CNN 2006): how important is sufficient risk assessment for engineered nanomaterials?

Prof. Dr. Harald F. Krug, born in 1952, is Head of „Materials-Biology Interactions Laboratory“ at Empa (St. Gallen) in Switzerland. Previously, he headed the Department of Molecular and Environmental Toxicology at the Research Centre in Karlsruhe, Germany. He studied Chemistry and Biology at the University Kassel and made his PhD-Thesis at the University of Göttingen in 1982 on the Regulation of circadian rhythmicity. He was postdoctoral stipend at the GSF Research Centre (1983-86) in Munich and changed his position to be a group leader at the research Centre in Karlsruhe. At the University of Karlsruhe he got a professorship in 1996 where he had his teaching activities and is recently appointed as “Titularprofessor” at the University of Berne since August 2008.

Actually he is the speaker of the “NanoCare“ consortium (2006-2009), a cooperation project of 13 industry, research and academic partners which carries out investigation on the possible adverse biological effects of nanomaterials funded by the German Ministry of Education and Research. Furthermore he is a member in several scientific societies and involved in the following research activities: German Society for Cell Biology (DGZ), Society of Hygiene, Environmental and Public Health Sciences – GHUP (formerly: Society for Hygiene and Environmental Medicine- GHU), Signal Transduction Society (STS), Environmental Mutagen Society (GUM), German Society for Biochemistry and Molecular Biology (GBM), DECHEMA Working Group "Responsible production and use of nanomaterials" (incl. Fachsektion Nanotechnologie), Nano-Embassadors of the "Deutsches Museum München". Recently he is appointed as expert for the DFG Ad hoc Working Group on „Nanotoxicology and Food“, the European Project „NanoMedRoundTable“, the CNT-Initiative, funded by the BMBF, and he as a member of the foundation board of the “GEN SUISSE” foundation and the IANH, the „International Alliance for NanoEHS Harmonization“. Additionally, he is active as reviewer for more then a dozen of international journals and funding agencies. Furthermore he is appointed into several working groups of the German Government (BMU) and the Swiss Government (BAG and BAfU).

Prof. Krug was awarded in 2006 with the cwi-Award of the German Ceramic Society and in 2007 with the Research Award for „Alternatives for Animal Testing“ of the State Parliament of Baden-Württemberg. He has authored over 100 publications, including journal articles, book chapters, and technical reports. His main interests are focused on the molecular mechanisms of nanoparticles and the establishing and validation of new cell culture/tissue models for studying the toxicity of nanomaterials.

 Tom Warwick

Tom Warwick (NanoInk, Inc., USA)

Opening up the Nanoscale World with Dip Pen Nanolithography®

Tom Warwick is General Manager of NanoInk in Europe and the Middle East. NanoInk, Inc. (Skokie, IL) is a company driven by technology to one of finding solutions to challenges facing the world as it comes to grips with nanotechnology. Using a licensed technology called Dip Pen Nanolithography® (DPN®), enabling processes which allow structures to be “written” onto a variety of materials using many different kinds of “inks” at scales of a few tens of nanometers, the company has brought nanofabrication to the desk-top of science worldwide.

There is huge potential for the exploitation of nanotechnology to the world of medicine though applied bioscience and biotechnology research. The pharmaceutical industry has shown the importance of research and new drug development. With many companies having greatly reduced streams of new potential drugs and existing patents running out, there is a clear the need to apply nanotechnology to this sector. With world-leading technology backed by top scientists, NanoInk has grown from a development stage company into a commercially focused nanofabrication business.

Europe demonstrates a leading role in the world of drug discovery. NanoInk brings divisions to meet these fast growing needs focusing on nanofabrication instrumentation, nanostem cell applications and nano biodiscovery. Warwick is tasked with building NanoInk’s profile and growing business across Europe and the Middle East.

Prior to joining NanoInk, Warwick built an excellent reputation in the world of nanotechnology and metrology helping to establish Veeco’s leadership of world markets over ten years where he was GM of Europe and head of worldwide sales for instrumentation. Starting with a BSc in Cell and Molecular Biology from the University of Essex (UK), Warwick gained initial experience in instrumentation with Oxford Instruments to become a results-driven business leader with a proven track record driving the advanced performance, growth and profitability of leading manufacturers in the high-tech, scientific instruments sector.

URL:http://www.nanoink.net

 Bob Irving

Bob Irving (Quintain Consulting Pty Ltd, Australia)

BioNanoTechnology Research for Commercialisation

Dr Bob Irving is a founding Director of Quintain Consulting Pty Ltd a specialist Australian Bionanotechnology Commercialisation Company and CEO of BioDetectors Pty Ltd an in vitro Diagnostics company developing and commercialising nanotechnology enhanced biomedical devices. The strategy being used is to work through these companies to take the nanotechnology inspired and enhanced developments into the global market.

From 2004 to 2009, Bob was Scientific and Commercial Director of Nanotechnology Victoria Ltd and Chief Operating Officer for NanoVentures Australia Ltd., responsible for commercialising the outcomes from the nanotechnology research and developments of Nanotechnology Victoria. This has resulted so far in several of the developments being licensed out in the areas of drug delivery, in vitro point of care diagnostics, in the materials areas for example nanopigments and environmental water sensors.

At Nanotechnology Victoria Bob was responsible for: the project portfolio, particularly in the BioNano areas, engagement with industry to deliver technology and commercialization outcomes, as well as providing advice to government, and involvement with safety and regulation.

Prior to joining Nanotechnology Victoria, Bob worked in CSIRO in the BioNanotechnology field and also CSIRO Health Sciences and Nutrition and the CRC for Diagnostics where he was responsible for the developments leading to the formation of start-up companies such as EvoGenix. In Canada Bob worked with private industry, the National Research Council Laboratories, and the Alberta Research Council. Bob has several years experience with developing recombinant antibodies and affinity maturation processes for therapeutics and diagnostics as part of the CRC for Diagnostics and a PhD through the Imperial Cancer Research Fund, London UK with a topic on Prostate Cancer.

 Steffi Friedrichs

Steffi Friedrichs (Nanotechnology Industries Association, Belgium)

Development of Markets and Regulations for Nanomaterials

Dipl. Chem. (TU Braunschweig, 1999), DPhil (Oxford, 2002), Dipl. L.a.T.H.E. (Oxford, 2003)
Dr Steffi Friedrichs is the Director of the Nanotechnology Industries Association (NIA), globally the only industries-focused trade association in nanotechnology; providing a sector-independent, responsible voice for the industrial nanotechnologies supply chains.

In this capacity, she has given evidence to numerous expert committees and regulatory organizations; she initiated in-depth programmes in support of the ongoing advancement of nanotechnologies and participated in many stakeholder debates and citizen’s engagement panels. Steffi joined the NIA from The Technology Partnership, where, as a Senior Nanotechnology Consultant, she was responsible for the development of nanotechnology innovations and contributed to the tendering and due diligence processes for the MNT Network (Department of Trade and Industry, UK Government). She was also a member of the Board of Directors of the Chicago Micro- & Nanotechnology Community (CMNC).

Steffi started her scientific career with an undergraduate degree in 'Diplom-Chemie' at the Technical University of Braunschweig (Germany), before taking a DPhil at the University of Oxford (UK), specialising in single-walled carbon nanotubes (both synthesis and toxicology). She subsequently held a Fellowship at Oxford University and a Lectureship in Nanotechnology at Cambridge University, where she developed and co-ordinated a Master’s Programme in Micro- & Nanotechnology Enterprise. In 2006, Steffi chaired the UK Committee for the Recognition of Nanoscience and –technology Educational Programmes (Institute of Nanotechnology), and is member of the Board of Editors for the journal NanoEducation.

 David M. Longo

David M. Longo (Finnegan, USA)

Collaboration Between Industry & Academia: Intellectual Property as a Foundation for Business Growth

Dr. Longo’s patent law practice includes client counseling, patent prosecution, opinions of counsel, and district court litigation. Dr. Longo’s experience encompasses a range of technical areas, including semiconductor materials and devices, semiconductor processing and characterization, photovoltaics, nanotechnology, advanced materials (including alloys and composites), alternative lithography technologies, fiber optics/optoelectronics, microelectromechanical systems (MEMS), medical devices, electronic communication devices, transmission electron microscopy (TEM), scanning electron microscopy (SEM), atomic force microscopy (AFM), and focused ion beam (FIB) microscopy/micromachining.

Prior to his legal career, Dr. Longo's experience in semiconductor materials and nanotechnology includes six years of research in thin film analysis and nanoscale printing technology while earning his M.S. and Ph.D. in Materials Science & Engineering at the University of Virginia. Dr. Longo’s Ph.D. research significantly contributed to a Defense Advanced Research Projects Agency (DARPA) project for development of a nanoscale printing technology for electronic materials and devices applicable to both planar and curved surfaces.

His dissertation was entitled "Development of a Deep Submicron Printing Technology." Dr. Longo’s M.S. academic research involved FIB microscopy, along with analytical and high resolution TEM to study nanoscale thin film deposition onto single-crystal silicon surfaces. From 1998 to 2000, Dr. Longo received five awards for his research and scholastic activities while a graduate student, and published several papers in such journals as Applied Physics Letters and Ultramicroscopy as well as conference proceedings.

Dr. Longo has lectured on current developments in U.S. patent law and the patenting process at technical meetings for the American Chemical Society (ACS), Materials Research Society (MRS), the American Society of Mechanical Engineers (ASME), and a joint ASM International / The Minerals Metals & Materials Society (TMS) conference. He has also presented several talks on alternative nanoscale printing technologies at technical conferences and seminars.

 Peter König

Peter König(GmbH, Saarbrücken - Germany)

Innovation through material development

Dr. Peter König * 1974 Chemist
He studied chemistry at University of Saarland in Saarbrücken and finished his Diplomas work in 2000 about “Reactions of novel Silanols with Alanes”. He made his PhD in 2004 in the working group of Prof. Dr. Dr. h.c. M. Veith about “New Metal-Ligands based on Silanols”. During that time he was co-worker on the DFG-SPP “Semiconductors and metal clusters as building blocks for organized structures”. Since 2007 he is scientific co-worker at the INM in the group Optical Materials of Dr. Peter William de Oliveira and is working on high refractive index coatings and materials for holography.

 Masum Khan

Masum Khan (Tesscorn Systems, India)

Nanotechnology—The Next Revolution

Masum Khan is Product Manager of Nanotechnology Division at Tesscorn Systems India Pvt.Ltd. An Electrical & Electronics Engineer with Eight Plus years of industrial experience. Professional responsibilities included design& development, installation & support in power electronics industry and Experience of three plus years in Product Management & Marketing, Sales & Support of systems for Nanotechnology Research.

Has Earned, Master of Engineering in Electrical from University Visvaswara college of Engineering, Bangalore. Actively involved in Nanotechnology research market in India. Worked with premier research organizations in India involved in nanotechnology research by providing them with high end scientific equipments.

 Mark Tilley

Mark Tilley (President & CEO of Unidym Inc.)

Novel CNT Based Films to Replace ITO in Electronic and Energy Applications

Dr. Mark Tilley is Chief Executive Officer of Unidym. He also serves as Vice President, Advanced Materials of Arrowhead Research Corporation (NASDAQ: ARWR) and is a Board Director at Nanotope Inc. Prior to joining Arrowhead, he spent 9 years at DSM N.V.; a $12B Netherlands based specialty performance materials and life science company. Most recently, he served as Senior Investment Manager with DSM's Corporate Venturing Arm and served on the boards of CreAgri, Novomer, Van Technologies, Harland Medical Systems and InMat. Prior to his work with DSM Ventures, Dr. Tilley was Vice President of Research and Business Development for DSM Desotech, an operating division of DSM that is the global market leader in fiber optic coatings and stereo lithographic resins.

During his tenure, he led marketing and technical teams, and built a nano-enabled flat panel displays materials business that was acquired by JSR in 2005. Dr. Tilley also co-founded Kriya Materials B.V., a venture capital backed nano-materials and coatings company based in the Netherlands. He holds a BSc in Chemistry from the University of Manchester, UK, a PhD in Photochemistry from North Dakota State University, and an MBA from Pepperdine University, California.

 Anirban Bandyopadhyay

Anirban Bandyopadhyay (NIMS, Japan)

Design and Synthesis of a 3D Nano Brain for Robotics

Dr. Anirban did his doctorate on Supramolecular electronics from the Indian Association for the Cultivation of Science (IACS), Kolkata, India; Asia's first research institute (est.1864). During his PhD he worked in Sheffield, UK on a USAF project on DNA nanoelectronics. In 2004, he was selected amongst 40 other scientists by MEXT, Japan from 26 countries who can work on futuristic projects.

He started working on building massively parallel bio-processor like our brains using molecules by setting up a state-of-the-art lab in Tsukuba, Japan, NIMS in 2005. In 2008 he joined as a permanent scientist of NIMS and as an Adjunct professor in Michigan Tech, USA. He is on the executive advisory board of a few scientific societies and organizations - apart from running his own "molecular intelligence" laboratory in NIMS, Tsukuba.

 Helmy Abouleish

Helmy Abouleish (Chair of Management Council, Industrial Modernization Council; Managing Director, Sekem, Egypt)

TBA

Helmy Abouleish - Graduate of Faculty of Commerce, Major in Business Administration of Cairo University and Marketing Diploma of American University in Cairo - is deeply involved in the development of SEKEM - an initiative started 1977 in the Egyptian desert striving for sustainable development in the fields of economy, culture and social / political life. Further to his engagement as Managing Director of the SEKEM Holding, Helmy Abouleish is extremely engaged in the national and international political sphere fostering responsible competitiveness, social entrepreneurship and the abatement of the huge problems of the 21st century, such as climate change and food security. Under his stewardship of its commercial arm,SEKEM Initiative received the “Right Livelihood Award 2003” for sustainable development, better known as “Alternative Nobel Prize”, and became a member of the Schwab Foundation for Outstanding Social Entrepreneurs.

Currently, he is the Managing Director of SEKEM Holding that consists of eight companies (SEKEM for Land Reclamation, Libra, Mizan, Lotus, Atos, Naturetex, Hator, Isis), which cover the fields of biodynamic agriculture cultivation, production of phyto-pharmaceuticals, organic textiles and foodstuff, with a capacity of 1600 people. Since 2007 Helmy Abouleish is Founder & Chairman of Ecotec (Ecological Technologies), established as a Holding company operating in the fields of: Production and sales of renewable energies equipment, Provision of renewable energies, Water treatment solutions, Clean Development Mechanism consulting, tailored IT solutions, Real estate development of Ecological Lodges, mining and glass processing.

From May 2005 until July 2006, he has been appointed as the Executive Director of the Industrial Modernisation Centre (IMC), the biggest development fund in Egypt funded by the EU and the Egyptian Government, aiming at improving sustainable competitiveness of Egyptian enterprises. Helmy Abouleish was the Chairman of the Egyptian Junior Business Association (EJB) from June 2004 to June 2006. He represented SEKEM in the Annual Meeting of the World Economic Forum 2004/05/06/07/08 as well as on various regional events of the World Economic Forum (WEF).

Founder and cofounder of various organizations including: The Egyptian National Competitiveness Council (ENCC), the International Association for Partnership (IAP), the Egyptian Biodynamic Association (EBDA), the Centre for Organic Agriculture in Egypt (COAE), SEKEM Development Foundation (SDF).

Chairman: The Egyptian National Competitiveness Council (ENCC), Management Council of the Industrial Modernization Centre (IMC)

Board Member : The Egyptian Environment Affairs Agency (EEAA) ,the German Arab Chamber of Industry & Commerce (GACIC), the Industrial Development Authority (IDA), the Industrial Training Council ( ITC), Science and Technological Development Fund (STDF), Federation of Egyptian Industries (FEI), Egyptian Energy Saving Council for Industry ( EESCI), the National Authority for Control and Pharmaceutical Research, the Agricultural Export Council (AEC), the Egyptian Exports Promotion Centre (EEPC ), the Agriculture Modernization Council (AMC), the Advisory Board of the National Council for Childhood and Motherhood (NCCM), the Steering Committee of the Agricultural Exports' traceability project, and the Egyptian Coalition for Transparency and Anticorruption.

Member : Arab Sustainability Leadership Group (ASLG), the Young Presidents’ Organization (YPO), the Arab Business Council (ABC), the International Association of Partnership (IAP), the Egypt’s International Economic Forum (EIEF), the Social Entrepreneurs in the World Economy Forum, the Egyptian Education & Employment Alliance (EEEA), the Confederation of Egyptian European Business Associations (CEEBA). Moreover, he is a member of the Business Council as well as the Educational Committee of the National Democratic Party (NDP). While being a member of the Selection panel of the Ashoka Foundation in Egypt, he is also a member of the Social Entrepreneur Council of the Schwab Foundation / WEF, the International Demeter Organization (IDO) and the International Federation of Organic Agriculture Movements (IFOAM).

Board of Trustees: Heliopolis University for Sustainable Development,and The Egyptian Junior Business Association (EJB).